J. V. Anandan

566 total citations
11 papers, 416 citations indexed

About

J. V. Anandan is a scholar working on Nephrology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, J. V. Anandan has authored 11 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 4 papers in Pharmacology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in J. V. Anandan's work include Dialysis and Renal Disease Management (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Erythropoietin and Anemia Treatment (2 papers). J. V. Anandan is often cited by papers focused on Dialysis and Renal Disease Management (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Erythropoietin and Anemia Treatment (2 papers). J. V. Anandan collaborates with scholars based in United States. J. V. Anandan's co-authors include Neeta B. Amin, Anatole Besarab, Ajay Gupta, Susan Vogel, Stanley Frinak, Muhammad Ahsan, Gregory L. Barkley, Jorge G. Burneo, Mark A. Touchette and Francis Dumler and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and Epilepsia.

In The Last Decade

J. V. Anandan

10 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. V. Anandan United States	7	233	153	112	76	54	11	416
Anne C. Halstead Canada	9	54 0.2×	65 0.4×	20 0.2×	12 0.2×	115 2.1×	14	399
James O. Ballard United States	10	68 0.3×	15 0.1×	28 0.3×	50 0.7×	12 0.2×	20	282
Anthony W. Czerwinski United States	12	18 0.1×	58 0.4×	8 0.1×	63 0.8×	60 1.1×	18	361
Fabiola Martín-del-Campo Mexico	11	42 0.2×	217 1.4×	7 0.1×	8 0.1×	28 0.5×	31	418
Oliver Darlington United Kingdom	9	48 0.2×	105 0.7×	21 0.2×	11 0.1×	12 0.2×	28	368
Amanda R. Tortorici United States	8	42 0.2×	307 2.0×	7 0.1×	9 0.1×	28 0.5×	9	491
Nicholas Dombros Canada	8	25 0.1×	184 1.2×	5 0.0×	10 0.1×	27 0.5×	14	250
Maher Jf United States	11	14 0.1×	155 1.0×	6 0.1×	25 0.3×	44 0.8×	34	289
Jean-Michel Pochet Belgium	11	28 0.1×	102 0.7×	15 0.1×	18 0.2×	19 0.4×	26	264
H.-H. Neumayer Germany	11	16 0.1×	193 1.3×	4 0.0×	41 0.5×	96 1.8×	24	560

Countries citing papers authored by J. V. Anandan

Since Specialization

Citations

This map shows the geographic impact of J. V. Anandan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. V. Anandan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. V. Anandan more than expected).

Fields of papers citing papers by J. V. Anandan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. V. Anandan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. V. Anandan. The network helps show where J. V. Anandan may publish in the future.

Co-authorship network of co-authors of J. V. Anandan

This figure shows the co-authorship network connecting the top 25 collaborators of J. V. Anandan. A scholar is included among the top collaborators of J. V. Anandan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. V. Anandan. J. V. Anandan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Burneo, Jorge G., J. V. Anandan, & Gregory L. Barkley. (2001). A Prospective Study of the Incidence of the Purple Glove Syndrome. Epilepsia. 42(9). 1156–1159. 50 indexed citations

Besarab, Anatole, Neeta B. Amin, Muhammad Ahsan, et al.. (2000). Optimization of Epoetin Therapy with Intravenous Iron Therapy in Hemodialysis Patients. Journal of the American Society of Nephrology. 11(3). 530–538. 210 indexed citations

Gupta, Ajay, Neeta B. Amin, Anatole Besarab, et al.. (1999). Dialysate iron therapy: Infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis. Kidney International. 55(5). 1891–1898. 45 indexed citations

Amin, Neeta B., et al.. (1999). Characterization of gentamicin pharmacokinetics in patients hemodialyzed with high-flux polysulfone membranes. American Journal of Kidney Diseases. 34(2). 222–227. 29 indexed citations

Padhi, I. Desmond, et al.. (1997). Interaction Between Tacrolimus and Erythromycin. Therapeutic Drug Monitoring. 19(1). 120–122. 17 indexed citations

Touchette, Mark A., Rakesh Patel, J. V. Anandan, Francis Dumler, & Barbara J. Zarowitz. (1995). Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease. American Journal of Kidney Diseases. 26(3). 469–474. 31 indexed citations

Anandan, J. V., et al.. (1993). Fee Structure for Investigational Drug Studies. American Journal of Health-System Pharmacy. 50(11). 2339–2343. 2 indexed citations

Anandan, J. V., et al.. (1993). Fee structure for investigational drug studies.. PubMed. 50(11). 2339–43. 4 indexed citations

Zarowitz, Barbara J., et al.. (1986). Continuous Arteriovenous Hemofiltration of Aminoglycoside Antibiotics in Critically Ill Patients. The Journal of Clinical Pharmacology. 26(8). 686–689. 22 indexed citations

10.

Anandan, J. V.. (1981). Reducing the number of formulary theophylline preparations. American Journal of Health-System Pharmacy. 38(4). 511–513. 6 indexed citations

11.

Anandan, J. V. & Gary R. Matzke. (1981). Nephropathy as a hazard of analgesic abuse. American Journal of Health-System Pharmacy. 38(10). 1536–1540.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact